Share Name | Share Symbol | Market | Type |
---|---|---|---|
Biome Grow Inc | CSE:BIO | CSE | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.005 | 0.005 | 0.005 | 0 | 00:00:00 |
THIS PRESS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Biosign Technologies Inc. (CNSX:BIO) (the "Company" or "Biosign") today announced that it intends to raise gross proceeds of up to CDN $4.5 million through a brokered private placement of common shares of the Company (the "Shares") at a price of 75 cents per common share (the "Offering"). The Company has retained Dundee Securities Corporation to act as lead placement agent along with Canaccord Financial Inc. as co-agent. Proceeds from the Offering are intended to be used as working capital to support commercialization of the Company's products and services, with emphasis on non-invasive monitoring of blood pressure and blood glucose, and for general corporate purposes. The Shares to be issued in connection with this Offering will be subject to a four month hold period from the share issuance date in accordance with the policies of the Canadian National Stock Exchange (CNSX Markets Inc.) and applicable securities laws. The Offering is subject to all necessary regulatory and stock exchange approvals. Closing of the Offering will be on or about March 25, 2010. About Biosign Technologies Inc. Biosign provides biomedical systems. Key applications include intelligent systems for non-invasive monitoring of common health risks associated with blood pressure, glucose, and medication. The core technology combines measurement, analysis, and rapid knowledge formation to support health monitoring across global markets. The UFIT(R) medical device technology powers quality data collection and analytics for clinical diagnostics, self-care, wellness, disease state evaluation and management, and remote patient monitoring. For more information on Biosign please visit http://www.biosign.com. This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.
1 Year Biome Grow Chart |
1 Month Biome Grow Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions